peritonsillar infiltration
Drug1.5 ml around each tonsil, 3 minutes before surgical incision as per group description
Other names: as in description
NCT Number: NCT01552096
The investigators postulate that the use of pre-incisional peritonsillar infiltration of tramadol or lidocaine reduces both the inflammatory response and postoperative analgesic consumption, without harmful effects. Therefore, the present study is designed to evaluate the effects of infiltration of tramadol or lidocaine on the postoperative acute-phase serum protein, C-reactive protein, and analgesic consumption after tonsillectomy.
Looking for future studies?
Notify Me2 year–6 year
All sexes
Interventional
Phase 2
Dammam University KFHU, Khobar, EP, Saudi Arabia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1.5 ml around each tonsil, 3 minutes before surgical incision as per group description
Other names: as in description
Time frame: 24 hours
CRP Acute phase protein
Time frame: 24 hours
MBP HR
Time frame: 24 hours
VAS The time to first request for analgesia and the number of subjects receiving meperidine during the first 12 hours will be recorded.
Time frame: 24 hours
postoperative stridor, laryngospasm, cyanosis, bleeding, seizures, sedation (four-point verbal rating scores (VRS): awake, drowsy, rousable or deep sleep); nausea and vomiting (0: no nausea; 1: nausea no vomiting; 2: nausea and vomiting), respiratory depression (ventilatory frequency 10), and desaturation (92%), at 0, 1, 2, 4, 6, 8, and 12 h after surgery.
Imam Abdulrahman Bin Faisal University
Other
A Comparative Study of the Effects of Pre-incisional Infiltration of Tramadol or Lidocaine on the Inflammatory Response After Tonsillectomy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07558044
Adenotonsillectomy, Neurologic Manifestations
Caracas, Miranda, Venezuela
View Trial DetailsNCT07433296
Anxiety Disorders, Mental Disorders
Samsun, Turkey (Türkiye)
View Trial DetailsNCT04725305
Hemorrhage, Neurologic Manifestations
Houston, Texas, United States
View Trial DetailsNCT03793816
Handling, Hemorrhage
Vienna, Austria
View Trial Details